Belay Winini, Labisso Wajana Lako, Tigeneh Wondemagegnehu, Kaba Mirgissa, Haileselassie Werissaw
Department of Reproductive Health and Health Service Management, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Pathology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Front Psychiatry. 2022 Aug 26;13:957592. doi: 10.3389/fpsyt.2022.957592. eCollection 2022.
Patients with breast cancer are assumed to be susceptible to anxiety and depression, while there is a lack of evidence about the epidemiology and underlying factors in Ethiopia. Hence, we aimed to assess the prevalence and predictors of anxiety and depression among patients with breast cancer in Ethiopia.
An institutional-based cross-sectional study was conducted among patients with breast cancer who were attending treatment at the Oncology Center of the Tikur Anbessa Specialized Hospital, the largest referral teaching hospital in Ethiopia. The Hospital Anxiety and Depression Scale (HDAS) was used to evaluate the anxiety and depression status of the participants, and a structured questionnaire was used to collect sociodemographic, socioeconomic, and clinical data from the participants. Medical records of the participants were reviewed to collect and correlate information about the grade and stage of cancer. An analysis was done using STATA 15.1.
The study included 333 randomly selected participants, of which 35.4% were on stage III and 33% on stage II, and 67.9% were on chemotherapy and surgery. The prevalence of anxiety and depression were 60.7 and 58.6%, respectively. Poor patient-provider interaction (adjusted odds ratio [AOR] = 4.5, 95% CI: 2.49, 8.12) and having no financial support (AOR = 2.83, 95% CI: 1.63, 4.91) were the significant predictors of anxiety. Age >49 years (AOR = 0.48, 95% CI: 0.25, 0.90), poor patient-provider interactions (AOR = 3.36, 95% CI: 1.87, 6.02), and having no financial support (AOR = 3.36, 95% CI: 1.95, 5.79) were the significant predictors of depression.
In this study, the prevalence of anxiety and depression was high among patients with breast cancer, and the lack of financial support and poor patient-provider interactions were significant predictors of anxiety and depression among these groups of patients. Patients with cancer need regular screening for mental health and better emotional support from their healthcare providers and families to prevent and treat anxiety and depression.
乳腺癌患者被认为易患焦虑症和抑郁症,然而在埃塞俄比亚,缺乏关于其流行病学及潜在因素的证据。因此,我们旨在评估埃塞俄比亚乳腺癌患者中焦虑症和抑郁症的患病率及预测因素。
在埃塞俄比亚最大的转诊教学医院提库尔·安贝萨专科医院肿瘤中心接受治疗的乳腺癌患者中开展了一项基于机构的横断面研究。采用医院焦虑抑郁量表(HADS)评估参与者的焦虑和抑郁状况,并使用结构化问卷收集参与者的社会人口学、社会经济和临床数据。查阅参与者的病历以收集并关联有关癌症分级和分期的信息。使用STATA 15.1进行分析。
该研究纳入了333名随机选择的参与者,其中35.4%处于III期,33%处于II期,67.9%正在接受化疗和手术。焦虑症和抑郁症的患病率分别为60.7%和58.6%。患者与医护人员互动不良(调整优势比[AOR]=4.5,95%置信区间:2.49,8.12)和没有经济支持(AOR=2.83,95%置信区间:1.63,4.91)是焦虑症的显著预测因素。年龄>49岁(AOR=0.48,95%置信区间:0.25,0.90)、患者与医护人员互动不良(AOR=3.36,95%置信区间:1.87,6.02)和没有经济支持(AOR=3.36,95%置信区间:1.95,5.79)是抑郁症的显著预测因素。
在本研究中,乳腺癌患者中焦虑症和抑郁症的患病率较高,缺乏经济支持和患者与医护人员互动不良是这些患者群体中焦虑症和抑郁症的显著预测因素。癌症患者需要定期进行心理健康筛查,并从医护人员和家人那里获得更好的情感支持,以预防和治疗焦虑症和抑郁症。